Lombard Odier Asset Management (USA)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.36M Sell
60,000
-40,000
-40% -$5.6M 0.87% 25
2025
Q4
$12.3M Hold
100,000
1.14% 20
2025
Q3
$11.1M Hold
100,000
0.74% 25
2025
Q2
$11.1M Hold
100,000
0.84% 23
2025
Q1
$11.2M Hold
100,000
0.88% 23
2024
Q4
$9.24M Buy
+100,000
New +$9M 0.68% 32
2024
Q2
Sell
-250,000
Closed -$18.3M 305
2024
Q1
$18.3M Buy
+250,000
New +$19.2M 0.44% 60
2020
Q4
Sell
-105,000
Closed -$6.63M 287
2020
Q3
$6.63M Hold
105,000
0.43% 56
2020
Q2
$8.08M Buy
105,000
+45,000
+75% +$3.45M 0.56% 45
2020
Q1
$4.49M Buy
+60,000
New +$4.15M 0.47% 56

Other funds holding GILD

Lombard Odier Asset Management (USA)'s GILD Position: Q1 2026 in Review

Lombard Odier Asset Management (USA) opened a new position in Gilead Sciences (GILD) in Q1 2026: 1,958 shares worth $273K. The stake represents 0.03% of the portfolio and ranks #207 among its holdings. This is a return to the name: Lombard Odier Asset Management (USA) previously reported a position in GILD as recently as Q1 2024.

Lombard Odier Asset Management (USA) first reported a position in GILD in Q2 2013 and has held it in 8 quarters since. The position peaked at $3.25M in Q4 2019. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Lombard Odier Asset Management (USA) held 1,958 shares of Gilead Sciences worth $273K as of Q1 2026.
  • Gilead Sciences was a new Lombard Odier Asset Management (USA) position in Q1 2026.
  • Gilead Sciences made up 0.03% of Lombard Odier Asset Management (USA)'s portfolio in Q1 2026, its #207 holding.
  • Lombard Odier Asset Management (USA) first reported a position in Gilead Sciences in Q2 2013 and has held it in 8 quarters since.
  • Lombard Odier Asset Management (USA)'s Gilead Sciences position peaked at $3.25M in Q4 2019.
  • 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2026, filed 15 May 2026.